Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Kristine Faerch"'
Autor:
Fatima Hoosen, Majken L. Pico, Julia H. Goedecke, Joel A. Dave, Jonas S. Quist, Kristine Færch, Louise G. Grunnet, Anniza de Villiers, Jens Aagaard-Hansen, Amy E. Mendham
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Human Immunodeficiency Virus (HIV) and type 2 diabetes (T2D) are amongst the leading causes of death in South Africa. The preferred first-line anti-retroviral treatment contains dolutegravir (DTG), shown to increase body weight, m
Externí odkaz:
https://doaj.org/article/3ddefa99091845cebf474ac9eec4c58b
Autor:
Tanja Fredensborg Holm, Flemming Witt Udsen, Kristine Færch, Morten Hasselstrøm Jensen, Bernt Johan von Scholten, Ole Kristian Hejlesen, Stine Hangaard
Publikováno v:
JMIR Research Protocols, Vol 13, p e50340 (2024)
BackgroundThere has been an increasing interest in the use of digital health lifestyle interventions for people with prediabetes, as these interventions may offer a scalable approach to preventing type 2 diabetes. Previous systematic reviews on digit
Externí odkaz:
https://doaj.org/article/830d824e99ce41c9a0ecde410fc7cdf8
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Time-restricted eating (TRE) has been suggested as a feasible dietary strategy in individuals with overweight. Disruptions in daily life e.g., severe illness can affect engagement in lifestyle interventions to obtain healthier bod
Externí odkaz:
https://doaj.org/article/47e0c6e21f234161810da22b1abb910f
Autor:
Nishal Kumar Pinna, Ranjit Mohan Anjana, Shruti Saxena, Anirban Dutta, Visvanathan Gnanaprakash, Gnanavadivel Rameshkumar, Sukumaran Aswath, Srividhya Raghavan, Coimbatore Subramanian Shanthi Rani, Venkatesan Radha, Muthuswamy Balasubramanyam, Archana Pant, Trine Nielsen, Torben Jørgensen, Kristine Færch, Alireza Kashani, Maria Camila Alvarez Silva, Henrik Vestergaard, Tue Haldor Hansen, Torben Hansen, Manimozhiyan Arumugam, Gopinath Balakrish Nair, Bhabatosh Das, Oluf Pedersen, Viswanathan Mohan, Sharmila Shekhar Mande
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-20 (2021)
Abstract Background Recent studies have indicated an association of gut microbiota and microbial metabolites with type 2 diabetes mellitus (T2D). However, large-scale investigation of the gut microbiota of “prediabetic” (PD) subjects has not been
Externí odkaz:
https://doaj.org/article/d353adefcde7441a9a9d3ea27684a4eb
Autor:
Camila Alvarez-Silva, Alireza Kashani, Tue Haldor Hansen, Nishal Kumar Pinna, Ranjit Mohan Anjana, Anirban Dutta, Shruti Saxena, Julie Støy, Ulla Kampmann, Trine Nielsen, Torben Jørgensen, Visvanathan Gnanaprakash, Rameshkumar Gnanavadivel, Aswath Sukumaran, Coimbatore Subramanian Shanthi Rani, Kristine Færch, Venkatesan Radha, Muthuswamy Balasubramanyam, Gopinath Balakrish Nair, Bhabatosh Das, Henrik Vestergaard, Torben Hansen, Sharmila Shekhar Mande, Viswanathan Mohan, Manimozhiyan Arumugam, Oluf Pedersen
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-13 (2021)
Abstract Background Type 2 diabetes (T2D), a multifactorial disease influenced by host genetics and environmental factors, is the most common endocrine disease. Several studies have shown that the gut microbiota as a close-up environmental mediator i
Externí odkaz:
https://doaj.org/article/aa5d473cc056406e8a1a606b374ea278
Autor:
Anna Jonsson, Sara E. Stinson, Signe S. Torekov, Tine D. Clausen, Kristine Færch, Louise Kelstrup, Niels Grarup, Elisabeth R. Mathiesen, Peter Damm, Daniel R. Witte, Marit E. Jørgensen, Oluf Pedersen, Jens Juul Holst, Torben Hansen
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-7 (2021)
Abstract Background In order to explore the pathophysiology underlying type 2 diabetes we examined the impact of gene variants associated with type 2 diabetes on circulating levels of glucagon during an oral glucose tolerance test (OGTT). Furthermore
Externí odkaz:
https://doaj.org/article/e3f981110d3e44d6a351d23680b8639c
Autor:
Kim K B Clemmensen, Jonas S Quist, Dorte Vistisen, Daniel R Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Jens J Holst, Torsten Lauritzen, Marit E Jørgensen, Signe Torekov, Kristine Færch
Publikováno v:
Endocrine Connections, Vol 9, Iss 4, Pp 279-288 (2020)
Fasting duration has been associated with lower fasting blood glucose levels, but higher 2-h post-load levels, and research has indicated an adverse effe ct of ‘weekend behavior’ on human metabolism. We investigated associations of fasting durati
Externí odkaz:
https://doaj.org/article/e235480fcdb24df28872c70ffada4f7d
Autor:
Kristine Færch, Hanan Amadid, Lea Bruhn, Kim Katrine Bjerring Clemmensen, Adam Hulman, Mathias Ried-Larsen, Martin Bæk Blond, Marit Eika Jørgensen, Dorte Vistisen
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
AimsThe oral glucose tolerance test (OGTT) is together with haemoglobin A1c (HbA1c) gold standard for diagnosing prediabetes and diabetes. The objective of this study was to assess the concordance between glucose values obtained from venous plasma ve
Externí odkaz:
https://doaj.org/article/a02f26a0decb4056854a99e42cd089b4
Autor:
Charlotte Janus, Dorte Vistisen, Hanan Amadid, Daniel R Witte, Torsten Lauritzen, Søren Brage, Anne-Louise Bjerregaard, Torben Hansen, Jens J Holst, Marit E Jørgensen, Oluf Pedersen, Kristine Færch, Signe S Torekov
Publikováno v:
Endocrine Connections, Vol 8, Iss 12, Pp 1607-1617 (2019)
Rationale: The hormone glucagon-like peptide-1 (GLP-1) decreases blood glucose and appetite. Greater physical activity (PA) is associated with lower incidence of type 2 diabetes. While acute exercise may increase glucose-induced response of GLP-1, it
Externí odkaz:
https://doaj.org/article/41090cf018364d4faa48a1639e5a6afb
Autor:
Julie R. Lundgren, Kristine Færch, Daniel R. Witte, Anna E. Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Jens J. Holst, Dorte Vistisen, Marit E. Jørgensen, Signe S. Torekov, Nanna B. Johansen
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract Background and aim Cardiovascular diseases (CVDs) are globally the leading cause of death and hypertension is a significant risk factor. Treatment with glucagon-like peptide-1 (GLP-1) receptor agonists has been associated with decreases in b
Externí odkaz:
https://doaj.org/article/2414a8a9200545269eced300e7a98d3d